» Articles » PMID: 30374413

Reversal of Homocysteine-induced Neurotoxicity in Rat Hippocampal Neurons by Astaxanthin: Evidences for Mitochondrial Dysfunction and Signaling Crosstalk

Overview
Date 2018 Oct 31
PMID 30374413
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated plasma level of homocysteine (Hcy) represents an independent risk for neurological diseases, and induction of oxidative damage is considered as one of the most important pathomechanisms. Astaxanthin (ATX) exhibits strong antioxidant activity in kinds of experimental models. However, the potential of ATX against Hcy-induced neurotoxicity has not been well explored yet. Herein, the neuroprotective effect of ATX against Hcy-induced neurotoxicity in rat hippocampal neurons was examined, and the underlying mechanism was evaluated. The results showed that ATX pre-treatment completely reversed Hcy-induced neurotoxicity through inhibiting cell apoptosis in rat primary hippocampal neurons. The mechanical investigation revealed that ATX effectively blocked Hcy-induced mitochondrial dysfunction by regulating Bcl-2 family and opening of mitochondrial permeability transition pore (MPTP). ATX pre-treatment also attenuated Hcy-induced oxidative damage via inhibiting the release of intracellular reactive oxide species (ROS) and superoxide anion through regulating MPTP opening. Moreover, normalization of MAPKs and PI3K/AKT pathways also contributed to ATX-mediated protective effects. Taken together, these results above suggested that ATX has the potential to reverse Hcy-induced neurotoxicity and apoptosis by inhibiting mitochondrial dysfunction, ROS-mediated oxidative damage and regulation of MAKPs and AKT pathways, which validated the strategy of using ATX could be a highly effective way in combating Hcy-mediated neurological disorders.

Citing Articles

Hexavalent Chromium Induces Neurotoxicity by Triggering Mitochondrial Dysfunction and ROS-Mediated Signals.

Zhang T, Feng L, Cui J, Tong W, Zhao H, Wu T Neurochem Res. 2023; 49(3):660-669.

PMID: 38010603 DOI: 10.1007/s11064-023-04063-y.


Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases: Expanding the Therapeutic Approaches by Plant-Derived Natural Products.

Zhang X, Wang L, Li B, Shi J, Xu J, Yuan M Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259422 PMC: 9961467. DOI: 10.3390/ph16020277.


Parkinson's Disease Risk and Hyperhomocysteinemia: The Possible Link.

Al-Kuraishy H, Al-Gareeb A, Elewa Y, Zahran M, Alexiou A, Papadakis M Cell Mol Neurobiol. 2023; 43(6):2743-2759.

PMID: 37074484 PMC: 10333143. DOI: 10.1007/s10571-023-01350-8.


Habitual Tea Consumption Increases the Incidence of Metabolic Syndrome in Middle-Aged and Older Individuals.

Yu S, Wang B, Li G, Guo X, Yang H, Sun Y Nutrients. 2023; 15(6).

PMID: 36986178 PMC: 10055940. DOI: 10.3390/nu15061448.


Formulation Approaches to Crystalline Status Modification for Carotenoids: Impacts on Dissolution, Stability, Bioavailability, and Bioactivities.

Liu W, Hsieh Y, Ko H, Wu Y Pharmaceutics. 2023; 15(2).

PMID: 36839810 PMC: 9965060. DOI: 10.3390/pharmaceutics15020485.


References
1.
Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

2.
Moustafa A, Hewedi D, Eissa A, Frydecka D, Misiak B . Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front Behav Neurosci. 2014; 8:343. PMC: 4186289. DOI: 10.3389/fnbeh.2014.00343. View

3.
Read D, Gorman A . Involvement of Akt in neurite outgrowth. Cell Mol Life Sci. 2009; 66(18):2975-84. PMC: 11115732. DOI: 10.1007/s00018-009-0057-8. View

4.
Shen H, Kuo C, Chou J, Delvolve A, Jackson S, Post J . Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 2009; 23(6):1958-68. PMC: 2698661. DOI: 10.1096/fj.08-123281. View

5.
Dickinson B, Chang C . Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011; 7(8):504-11. PMC: 3390228. DOI: 10.1038/nchembio.607. View